Using Caenorhabditis elegans to study serpinopathies

Methods in Enzymology

Volumn 499, Issue , 2011, Pages 259-281

  Long, Olivia S ^a   Gosai, Sager J ^a   Kwak, Joon Hyeok ^a   King, Dale E ^a   Perlmutter, David H ^a   Silverman, Gary A ^a   Pak, Stephen C ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Caenorhabditis elegans; High content screening; Protein polymerization; Serpinopathies

Indexed keywords

AGAROSE; DNA; GREEN FLUORESCENT PROTEIN; PLASMID DNA; SERINE PROTEINASE INHIBITOR;

ARTICLE; AUTOMATION; CAENORHABDITIS ELEGANS; DRUG RESEARCH; DRUG SCREENING; FOOD PROCESSING; GENETIC DISORDER; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SERPINOPATHY; TRANSGENE; TRANSGENIC ANIMAL; TRANSGENICS; VECTOR CONTROL;

CAENORHABDITIS ELEGANS;

EID: 79959371160     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386471-0.00013-4     Document Type: Chapter

References (34)

1. D. Belorgey Protein misfolding and the serpinopathies Prion 1 1 2007 15 20
2. K.H. Bleicher Hit and lead generation: Beyond high-throughput screening Nat. Rev. Drug Discov. 2 5 2003 369 378 (Pubitemid 37361707)
3. M. Chalfie Green fluorescent protein as a marker for gene expression Science 263 5148 1994 802 805 (Pubitemid 24093206)
4. Evans T.C. Transformation and microinjection The C. elegans Research Community 2006 (WormBook, ed.), WormBook, doi/10.1895/wormbook.1.108.1 http://www.wormbook.org
5. A. Fire, S.W. Harrison, and D. Dixon A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans Gene 93 2 1990 189 198 (Pubitemid 20350757)
6. K.A. Giuliano Systems cell biology based on high-content screening Methods Enzymol. 414 2006 601 619 (Pubitemid 44716243)
7. M.P. Gleeson Generation of a set of simple, interpretable ADMET rules of thumb J. Med. Chem. 51 4 2008 817 834 (Pubitemid 351304691)
8. P. Gleeson ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters Bioorg. Med. Chem. 17 16 2009 5906 5919
9. B. Gooptu, U.I. Ekeowa, and D.A. Lomas Mechanisms of emphysema in alpha1-antitrypsin deficiency: Molecular and cellular insights Eur. Respir. J. 34 2 2009 475 488
10. S.J. Gosai, J.H. Kwak, C.J. Luke, O.S. Long, D.E. King, K.J. Kovatch, P.A. Johnston, T.Y. Shun, J.S. Lazo, D.H. Perlmutter, G.A. Silverman, and S.C. Pak Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin alpha1- antitrypsin Z PLoS ONE 5 11 2010 e15460
11. S.A. Haney High-content screening moves to the front of the line Drug Discov. Today 11 1920 2006 889 894 (Pubitemid 44403188)
12. O. Hobert PCR fusion-based approach to create reporter gene constructs for expression analysis in transgenic C. elegans Biotechniques 32 4 2002 728 730 (Pubitemid 34298696)
13. O. Hobert, and P.M. Loria Uses of GFP in Caenorhabditis elegans Kain Chalfie, Green Fluorescent Protein: Properties, Applications and Protocols 2nd edn 2005 John Wiley & Sons, Inc. Hoboken, New Jersey
14. J. Hodgson ADMETturning chemicals into drugs Nat. Biotechnol. 19 8 2001 722 726
15. I. Hope C. elegans: A practical approach 1999 Oxford University Press New York
16. P.A. Johnston, and P.A. Johnston Cellular platforms for HTS: Three case studies Drug Discov. Today 7 6 2002 353 363 (Pubitemid 34226655)
17. P.A. Johnston HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus Assay Drug Dev. Technol. 5 6 2007 737 750
18. P.A. Johnston Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents Assay Drug Dev. Technol. 6 4 2008 505 518
19. P.A. Johnston Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library Assay Drug Dev. Technol. 7 3 2009 250 265
20. D.A. Lomas, and R.W. Carrell Serpinopathies and the conformational dementias Nat. Rev. Genet. 3 10 2002 759 768
21. C. Mello, and A. Fire DNA transformation Methods Cell Biol. 48 1995 451 482
22. C.C. Mello Efficient gene transfer in C. elegans: Extrachromosomal maintenance and integration of transforming sequences EMBO J. 10 12 1991 3959 3970 (Pubitemid 21905425)
23. D. Nickischer Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation Methods Enzymol. 414 2006 389 418 (Pubitemid 44716234)
24. P.G. Okkema Sequence requirements for myosin gene expression and regulation in Caenorhabditis elegans Genetics 135 2 1993 385 404 (Pubitemid 23307595)
25. S.C. Pak SRP-2 is a cross-class inhibitor that participates in postembryonic development of the nematode Caenorhabditis elegans: Initial characterization of the clade L serpins J. Biol. Chem. 279 15 2004 15448 15459 (Pubitemid 38618945)
26. D.H. Perlmutter Liver injury in alpha1-antitrypsin deficiency: An aggregated protein induces mitochondrial injury J. Clin. Invest. 110 11 2002 1579 1583 (Pubitemid 35424232)
27. V. Praitis Creation of low-copy integrated transgenic lines in Caenorhabditis elegans Genetics 157 3 2001 1217 1226 (Pubitemid 32225014)
28. D.A. Rudnick, and D.H. Perlmutter Alpha-1-antitrypsin deficiency: A new paradigm for hepatocellular carcinoma in genetic liver disease Hepatology 42 3 2005 514 521 (Pubitemid 41233640)
29. G.A. Silverman, D.A. Lomas, and N.J. Huckensack Molecular and Cellular Aspects of the Serpionpathies and Disorders in Serpin Activity 2007 World Scientific Publishing Co. Pte. Ltd Singapore
30. T. Stiernagle Maintenance of C. elegans I. Hope, C. elegans: A Practical Approach 1999 Oxford University Press Oxford, UK 51 67
31. D.T. Stinchcomb Extrachromosomal DNA transformation of Caenorhabditis elegans Mol. Cell. Biol. 5 12 1985 3484 3496 (Pubitemid 16233056)
32. T. Sveger The natural history of liver disease in alpha 1-antitrypsin deficient children Acta Paediatr. Scand. 77 6 1988 847 851 (Pubitemid 19008615)
33. O.J. Trask Jr. Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform Methods Enzymol. 414 2006 419 439 (Pubitemid 44716235)
34. R.G. Williams Generation and characterization of a stable MK2-EGFP cell line and subsequent development of a high-content imaging assay on the Cellomics ArrayScan platform to screen for p38 mitogen-activated protein kinase inhibitors Methods Enzymol. 414 2006 364 389 (Pubitemid 44716233)